journal article·2022-06-23Open access

Fast and Efficient Synthesis of Racemic Baloxavir Catalyzed by Strong Solid Acid under Microwave Conditions

Yiyun Wang, Xiaofang Lv, Zihui Meng, Zhibin Xu, Zhonghui Zheng, Jiarong Li, Min Xue

Crystals· Volume 12· Issue 7

Abstract

The compound (±)-12aR-12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-7-hydroxy-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione is the intermediate of baloxavir marboxil. In the literature, traditional heating methods and common acid catalysts are used, which result in long reaction times and a low yield. Therefore, finding an efficient and environmentally friendly synthetic route is necessary. In this study, (±)-12aR-12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-7-benzyloxy-3,4,12,12a-tetrahydro-1h-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione (compound 3) was synthesized using a sulfonate resin solid acid catalyst (HND-580) under microwave conditions. The benzyl group was removed without further purification, and an intermediate, racemic baloxavir, was obtained under microwave irradiation. The total yield of the two steps was 78%. This method greatly reduces the reaction time and improves production efficiency.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Fluorine in Organic Chemistry · Synthesis and Reactions of Organic Compounds · Synthesis and Biological Evaluation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China

Shandong Xinhua Pharmaceutical Co., Ltd., No.1 Lutai Avenue, Zibo 255086, China

References (29)

Show source-provided references
2. Novel oral anti-influenza drug candidate AV508010.1093/jac/dku074 ↗
3. Compans, R.W., and Oldstone, M.B.A. (2014). Enhancement of influenza virus transmission by gene reassortment. Influenza Pathogenesis and Control-Volume I., Springer International Publishing.10.1007/978-3-319-11155-1 ↗
4. Fujita, J. (2021). The new anti-influenza drug baloxavir marboxil: Can influenza viruses with reduced susceptibility to baloxavir maintain viral fitness?. Influenza: Advances in Diagnosis and Management, Springer.10.1016/j.resinv.2019.10.005 ↗
5. Research on new anti-influenza drug baloxavir marboxil
6. Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts10.1056/NEJMoa1915341 ↗
7. In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit10.1016/j.antiviral.2018.10.008 ↗
8. Baloxavir: First Global Approval10.1007/s40265-018-0899-1 ↗
9. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents10.1056/NEJMoa1716197 ↗
10. characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil10.1038/s41598-018-27890-4 ↗
11. Influenza viruses resistant to the antiviral drug oseltamivir: Transmission studies in ferrets10.1086/424572 ↗
12. Delayed dosing of S-033188, a novel inhibitor of influenza virus cap-dependent endonuclease, exhibited significant reduction of viral titer and mortality in mice infected with influenza a virus10.1093/ofid/ofx163.1210 ↗
13. Cap-dependent endonuclease inhibitor S-033188 for the treatment of influenza: Results from a phase 3, randomized, double-blind, placebo- and active-controlled study in otherwise healthy adolescents and adults with seasonal influenza10.1093/ofid/ofx180.001 ↗
14. Kawai, M. (2020). Pharmaceutical Compositions Containing Substituted Polycyclic Pyridone Derivatives and Prodrug Thereof. (10,759,814), U.S. Patent.
15. Okamoto, K., Ueno, T., Hato, Y., Hakogi, T., Majima, S., Yamao, N., and Ochiai, K. (2019). Method for Stereoselectively Producing Substituted Polycyclic Pyridone Derivative. (Application No. WO2019/070059), International Patent.
16. Review of the patent literature: Synthesis and final forms of antiviral drugs tecovirimat and baloxavir marboxil10.1021/acs.oprd.9b00144 ↗
17. Development of a Quality Controllable and Scalable Process for the Preparation of 7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol: A Key Intermediate for baloxavir marboxil10.1021/acs.oprd.9b00389 ↗
18. Evaluation of drug-drug interaction potential between baloxavir marboxil and oseltamivir in healthy subjects10.1007/s40261-018-0697-2 ↗
19. Safety, tolerability, and pharmacokinetics of the novel anti-influenza agent baloxavir marboxil in healthy adults: Phase I study findings10.1007/s40261-018-0710-9 ↗
20. LB16. Phase 3 Trial of Baloxavir Marboxil in High-Risk Influenza Patients (CAPSTONE-2 Study)10.1093/ofid/ofy229.2190 ↗
21. Shibahara, S., Fukui, N., Maki, T., and Anan, K. (2017). Method for Producing Substituted Polycyclic Pyridone Derivative and Crystal. (WO2017221869A1).
22. Zheng, X., Zhang, Y., Fu, C., and Wu, Y. (2019). A synthetic method of novel Tamiflu. (109504721A), CN Patent.
23. Tang, C., Ren, Q., and Luo, H. (2019). Influenza Virus Replication Inhibitor and Use Thereof. (WO 2019/052565A1,).
24. Synthesis and Anti-Influenza Virus Effects of Novel Substituted Polycyclic Pyridone Derivatives Modified from Baloxavir10.1021/acs.jmedchem.1c00979 ↗
25. The use of microwave ovens for rapid organic synthesis10.1016/S0040-4039(00)83996-9 ↗
26. Misono, M., and Okuhara., T. (1993). Solid superacid catalysts. CHEMTECH, 23, Available online: https://www.osti.gov/biblio/5465998.
27. Synthesis of solid superacid catalyst with an acid strength of H0⩽–16.0410.1039/C39800000851 ↗
28. Recent progress in solid superacid10.1016/S0166-9834(00)82131-4 ↗
29. Amberlyst-15 in Ionic Liquid: An Efficient and Recyclable Reagent for Nucleophilic Substitution of Alcohols and Hydroamination of Alkenes10.1002/ejoc.201000456 ↗